测量耐受性的多维方面.
Sandra A Mitchell1, Rachel D Altshuler2, Diane C St Germain3
1Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA.
Cancer
|October 22, 2025
概括
了解癌症治疗的安全性和耐受性至关重要,因为新疗法正在发展. 本评论澄清了这些不同的概念,并建议将耐受性纳入未来的癌症临床试验.
科学领域:
- 在瘤学瘤学.
- 临床药理学 临床药理学
背景情况:
- 新兴的癌症疗法需要更清楚地了解它们的安全性和耐受性.
- 安全性和耐受性是癌症治疗评估中的不同但相关的概念.
- 患者为中心的因素显著影响癌症治疗的耐受性.
研究的目的:
- 在不良事件报告框架内定义安全性,耐受性,不良事件和毒性.
- 确定评估癌症治疗耐受性的措施和总结指标.
- 建议将耐受性评估纳入未来癌症临床试验的设计和解释.
主要方法:
- 概念分析和关键术语的定义:安全性,耐受性,不良事件,毒性.
- 审查现有的治疗耐受性的措施和指标.
- 讨论对临床试验方法学的影响.
主要成果:
- 区分安全性 (没有伤害) 和耐受性 (患者接受副作用).
- 确定影响耐受性的多维因素,包括不良事件概况和患者特定元素.
- 关于将耐受性纳入癌症试验设计的建议框架.
结论:
- 清晰的定义对于评估新的癌症疗法至关重要.
- 耐受性是一个复杂的,多维的结构,受治疗和患者因素的影响.
- 未来的癌症试验应该系统地评估和报告治疗耐受性,以提高患者的护理和治疗选择.
相关概念视频
Measurement of Bioavailability: Pharmacodynamic Methods
230
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
230
Measurement of Bioavailability: Pharmacokinetic Methods
255
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
255
Dosage Regimen: Individualization
166
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
166
Quantitative Aspects of Drug-Receptor Interaction
1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K
Therapeutic Drug Monitoring: Drug Analysis Methods
176
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
176
Therapeutic Drug Monitoring: Affecting Factors
200
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
200


